HPV-related diseases represent a major cause of morbidity and mortality, although effective
HPV vaccines are available, potentially allowing for the elimination of these malignancies …

Human papillomavirus (HPV) infection is responsible for many cancers in both women and
men. Cervical cancer, caused by HPV, is the fourth most common cancer among women …

Background Given the accumulating evidence that one-dose vaccination could provide high
and sustained protection against human papillomavirus (HPV) infection and related …

Background Despite the high burden of cervical cancer, access to preventive measures
remains low in India. A single-dose immunisation schedule could facilitate the scale-up of …

Background A key barrier to cervical cancer elimination in China is low human
papillomavirus (HPV) vaccine uptake, which is limited by supply constraints, high prices, and …

Summary Background In 2020, the World Health Organization (WHO) launched its initiative
to eliminate cervical cancer as a public health problem. To inform global efforts for countries …

ABSTRACT HPV vaccine uptake remains low in China, especially among girls. Recently,
China has initiated a pilot program on HPV immunization for girls 9–14. From November to …

Objectives Acquiring herd immunity through vaccination is the best way to curb the COVID-
19 infection. Many countries have attempted to reach the herd immunity threshold as early …

Vaccines may play an important role in cancer prevention. This bibliometric study in the field
of vaccine and cancer prevention is designed to evaluate key research advances, identify …

The human papillomavirus is known to cause cervical and anogenital cancer and benign
anogenital and cutaneous warts. Both males and females can contract the virus during …